The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100.
作者:
主题词
动物(Animals);抗HIV药(Anti-HIV Agents);CHO细胞(CHO Cells);钙信号(Calcium Signaling);细胞系(Cell Line);细胞, 培养的(Cells, Cultured);趋化因子CXCL12(Chemokine CXCL12);仓鼠亚科(Cricetinae);仓鼠属(Cricetulus);荧光抗体技术(Fluorescent Antibody Technique);HIV感染(HIV Infections);HIV-1(HIV-1);人类(Humans);小鼠(Mice);小鼠, SCID(Mice, SCID);蛋白质结合(Protein Binding);大鼠(Rats);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);受体, CXCR4(Receptors, CXCR4)
DOI
10.1128/AAC.01727-08
PMID
19451305
发布时间
2021-10-20
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文